Stephen J. Haleen

1.0k total citations
31 papers, 822 citations indexed

About

Stephen J. Haleen is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Stephen J. Haleen has authored 31 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 15 papers in Molecular Biology and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Stephen J. Haleen's work include Nitric Oxide and Endothelin Effects (22 papers), Receptor Mechanisms and Signaling (11 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Stephen J. Haleen is often cited by papers focused on Nitric Oxide and Endothelin Effects (22 papers), Receptor Mechanisms and Signaling (11 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Stephen J. Haleen collaborates with scholars based in United States, Canada and United Kingdom. Stephen J. Haleen's co-authors include Joan A. Keiser, Harriet W. Hamilton, Elwood E. Reynolds, R. Steffen, Kathleen M. Welch, Annette M. Doherty, Wayne L. Cody, Mary Flynn, Ronald E. Weishaar and John X. He and has published in prestigious journals such as Circulation Research, Biochemical and Biophysical Research Communications and Hypertension.

In The Last Decade

Stephen J. Haleen

31 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen J. Haleen United States 18 377 371 294 138 121 31 822
Torsten Minuth Germany 14 563 1.5× 584 1.6× 304 1.0× 130 0.9× 90 0.7× 17 1.2k
Iain G. Dougall United Kingdom 17 235 0.6× 528 1.4× 103 0.4× 102 0.7× 98 0.8× 29 939
Toichi Abiru Japan 15 274 0.7× 236 0.6× 149 0.5× 37 0.3× 119 1.0× 22 653
Ross Bentley United States 19 212 0.6× 375 1.0× 369 1.3× 79 0.6× 143 1.2× 33 951
Anthony H. Ingall United Kingdom 12 85 0.2× 240 0.6× 173 0.6× 54 0.4× 170 1.4× 14 789
David P. Wilson Canada 16 251 0.7× 680 1.8× 241 0.8× 70 0.5× 35 0.3× 36 1.1k
V. L. Lakomkin Russia 18 305 0.8× 333 0.9× 296 1.0× 25 0.2× 57 0.5× 81 948
Alain Le Bec France 10 175 0.5× 482 1.3× 210 0.7× 41 0.3× 102 0.8× 11 643
Naoyuki Kitajima Japan 12 152 0.4× 431 1.2× 236 0.8× 53 0.4× 35 0.3× 16 892
Wolfgang Landgraf Germany 20 388 1.0× 689 1.9× 160 0.5× 37 0.3× 25 0.2× 55 1.3k

Countries citing papers authored by Stephen J. Haleen

Since Specialization
Citations

This map shows the geographic impact of Stephen J. Haleen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Haleen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Haleen more than expected).

Fields of papers citing papers by Stephen J. Haleen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Haleen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Haleen. The network helps show where Stephen J. Haleen may publish in the future.

Co-authorship network of co-authors of Stephen J. Haleen

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Haleen. A scholar is included among the top collaborators of Stephen J. Haleen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Haleen. Stephen J. Haleen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Haleen, Stephen J., et al.. (2002). The Endothelin A Receptor Antagonists PD 156707 (CI-1020) and PD 180988 (CI-1034) Reverse the Hypoxic Pulmonary Vasoconstriction in the Perinatal Lamb. Journal of Pharmacology and Experimental Therapeutics. 302(2). 672–680. 18 indexed citations
3.
Haleen, Stephen J., et al.. (2000). The Endothelin-A-Receptor Antagonist PD180988 (CI-1034) Selectively Reverses the Pulmonary Vasoconstrictor Response to Hypoxia in the Lamb. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S331–S333. 17 indexed citations
4.
Schroeder, Richard L., Joan A. Keiser, Xue‐Min Cheng, & Stephen J. Haleen. (1998). PD 142893, SB 209670, and BQ 788 Selectively Antagonize Vascular Endothelial Versus Vascular Smooth Muscle ETB-Receptor Activity in the Rat. Journal of Cardiovascular Pharmacology. 32(6). 935–943. 3 indexed citations
5.
Haleen, Stephen J., et al.. (1998). The Effect of the ETAReceptor Antagonist (CI-1020) in Rats with Established Hypoxic Pulmonary Hypertension. Pulmonary Pharmacology & Therapeutics. 11(2-3). 173–176. 5 indexed citations
6.
Haleen, Stephen J., Richard L. Schroeder, Kathleen M. Welch, et al.. (1998). Efficacy of CI-1020, an Endothelin-A Receptor Antagonist, in Hypoxic Pulmonary Hypertension. Journal of Cardiovascular Pharmacology. 31. S331–S335. 15 indexed citations
7.
Uprichard, Andrew C. G., Alan Metz, Hussein Hallak, & Stephen J. Haleen. (1998). PD‐156707: A Selective Endothelin‐A Receptor Antagonist. Cardiovascular Drug Reviews. 16(2). 89–104. 7 indexed citations
8.
Flynn, Michael A., Stephen J. Haleen, Kathleen M. Welch, Xue‐Min Cheng, & Elwood E. Reynolds. (1998). Endothelin B Receptors on Human Endothelial and Smooth-Muscle Cells Show Equivalent Binding Pharmacology. Journal of Cardiovascular Pharmacology. 32(1). 106–116. 11 indexed citations
9.
Patt, William C., Joseph T. Repine, Annette M. Doherty, et al.. (1997). γ-Carbamate butenolide analogues as potent ETA selective endothelin receptor antagonists and prodrugs. Bioorganic & Medicinal Chemistry Letters. 7(3). 297–302. 3 indexed citations
10.
Patt, William C., Jeremy J. Edmunds, Joseph T. Repine, et al.. (1997). Structure−Activity Relationships in a Series of Orally Active γ-Hydroxy Butenolide Endothelin Antagonists. Journal of Medicinal Chemistry. 40(7). 1063–1074. 36 indexed citations
11.
Haleen, Stephen J. & Xue‐Min Cheng. (1997). Cardiopulmonary indications for endothelin receptor antagonists: review of recent efficacy trials. Expert Opinion on Investigational Drugs. 6(5). 475–487. 4 indexed citations
12.
Cody, Wayne L., John X. He, Daniele M. Leonard, et al.. (1995). Structure-activity relationships of the potent combined endothelinA/endothelinB receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21 (PD 142893): development of endothelinB receptor selective antagonists. Journal of Medicinal Chemistry. 38(15). 2809–2819. 21 indexed citations
13.
Doherty, Annette M., Wayne L. Cody, Kathleen M. Welch, et al.. (1993). In Vitro and In Vivo Studies with a Series of Hexapeptide Endothelin Antagonists. Journal of Cardiovascular Pharmacology. 22(Supplement 8). S98–S102. 54 indexed citations
14.
Flynn, Mary, et al.. (1993). ETA and ETB Receptors Coexist on Rabbit Pulmonary Artery Vascular Smooth Muscle Mediating Contraction. Biochemical and Biophysical Research Communications. 196(1). 209–215. 73 indexed citations
15.
Haleen, Stephen J., et al.. (1993). Why Big Endothelin-1 Lacks a Vasodilator Response. Journal of Cardiovascular Pharmacology. 22(Supplement 8). S271–S273. 12 indexed citations
16.
17.
Haleen, Stephen J., R. Steffen, Ila Sircar, et al.. (1989). PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking properties.. Journal of Pharmacology and Experimental Therapeutics. 250(1). 22–30. 5 indexed citations
18.
Haleen, Stephen J., Robert Steffen, & Ronald E. Weishaar. (1989). Species differences in the positive inotropic response to DPI 201-106, a novel cardiotonic agent. Canadian Journal of Physiology and Pharmacology. 67(11). 1460–1463. 5 indexed citations
19.
Hamilton, Harriet W., et al.. (1987). Correlation of adenosine receptor affinities and cardiovascular activity. Life Sciences. 41(20). 2295–2302. 28 indexed citations
20.
Hamilton, Harriet W., Daniel F. Ortwine, Donald F. Worth, et al.. (1985). Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application. Journal of Medicinal Chemistry. 28(8). 1071–1079. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Torsten Minuth Breakdown of academic impact, for papers by Iain G. Dougall Breakdown of academic impact, for papers by Toichi Abiru Breakdown of academic impact, for papers by Ross Bentley Breakdown of academic impact, for papers by Anthony H. Ingall Breakdown of academic impact, for papers by David P. Wilson Breakdown of academic impact, for papers by V. L. Lakomkin Breakdown of academic impact, for papers by Alain Le Bec Breakdown of academic impact, for papers by Naoyuki Kitajima Breakdown of academic impact, for papers by Wolfgang Landgraf
Rankless by CCL
2026